Author:
Li Zhaoxia,Gao Zhiliang,Chang Cong,Gao Zhuanglei
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference57 articles.
1. Thijs, R. D., Surges, R., O'Brien, T. J., Sander, J. W. (2019). Epilepsy in adults. The Lancet. 16;393(10172):689–701.
2. Ettore, B. (2020). The epidemiology of epilepsy. Neuroepidemiology, 54, 185–191.
3. GBD 2016 Epilepsy Collaborators. (2019). Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 357–375.
4. Anovadiya, A. P., Sanmukhani, J. J., & Tripathi, C. B. (2012). Epilepsy: novel therapeutic targets. Journal of Pharmacology & Pharmacotherapeutics, 3, 112–7.
5. Paudel, Y. N., Angelopoulou, E., Piperi, C., Gnatkovsky, V., Othman, I., & Shaikh, M. F. (2020). From the molecular mechanism to pre-clinical results: Antiepileptic effects of fingolimod. Current Neuropharmacology, 18, 1126–2113.